Skye Bioscience, Inc.
SKYE· Nasdaq
SKYESkye Bioscience, Inc.
Filed Mar 27, 2015 · 10-K · 86 days after period end · 0001557240-15-000195
derived · Computed from the longer spans the company filed.
| Metric | Q4 2014dderived from reported figures | Q4 2012dderived from reported figures |
|---|---|---|
| Net Income | -$1.70M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Skye Bioscience, Inc. · CIK 1516551 · Engraved from SEC EDGAR
ended Dec 31, 2014 · filed Mar 27, 2015 · 86 d after period end
